X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GLYC

Closed

Glycomimetics Inc

14.62
+14.46 (+9210.19%)
Last Update: 18 Jun 2025 16:30:00
Yesterday: 0.157
Day's Range: 11.06 - 15.81
Send
When Written:
 
1.26
GlycoMimetics Inc. is a clinical-stage biotechnology company that is focused on discovering and developing novel small-molecule drugs that mimic the activity of carbohydrates, which are essential components of many biological processes. The company's lead product candidate, uproleselan, is being developed for the treatment of acute myeloid leukemia (AML) and other hematologic malignancies. GlycoMimetics is also developing several other product candidates for the treatment of cancer, sickle cell disease, and other indications. The company was founded in 2003 and is headquartered in Rockville, Maryland.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X